BP-1249

N/A

Report date: 2023/02/18 16:52:59

NME

Base Information

Drug NameBP-1249

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUndefined mechanism

TargetsNot applicable

Therapy Area/IndicationsDermatitis, Atopic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBridge Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBridge Pharma

Active IndicationsN/A

Inactive IndicationsDermatitis, Atopic

ATC CodeN/A